{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT01576328",
      "OrgStudyIdInfo": {
        "OrgStudyId": "MSB-DM003"
      },
      "Organization": {
        "OrgFullName": "Mesoblast, Ltd.",
        "OrgClass": "INDUSTRY"
      },
      "BriefTitle": "Safety Study of Mesenchymal Precursor Cells in Type 2 Diabetes",
      "OfficialTitle": "A Randomized, Placebo-Controlled Dose-Escalation Study to Assess the Safety and Tolerability of a Single Intravenous Infusion of Allogeneic Mesenchymal Precursor Cells (MPCs) in Patients With Type 2 Diabetes Sub-optimally Controlled on Metformin"
    },
    "StatusModule": {
      "StatusVerifiedDate": "June 2020",
      "OverallStatus": "Completed",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "April 2012"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "October 2013",
        "PrimaryCompletionDateType": "Actual"
      },
      "CompletionDateStruct": {
        "CompletionDate": "October 2015",
        "CompletionDateType": "Actual"
      },
      "StudyFirstSubmitDate": "April 9, 2012",
      "StudyFirstSubmitQCDate": "April 10, 2012",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "April 12, 2012",
        "StudyFirstPostDateType": "Estimate"
      },
      "LastUpdateSubmitDate": "June 1, 2020",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "June 2, 2020",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Mesoblast, Ltd.",
        "LeadSponsorClass": "INDUSTRY"
      }
    },
    "OversightModule": {
      "OversightHasDMC": "Yes"
    },
    "DescriptionModule": {
      "BriefSummary": "This study is being conducted to assess the overall safety and tolerability of a single intravenous infusion of three doses of Mesenchymal Precursor Cells versus Placebo in subjects with Type 2 Diabetes inadequately controlled on Metformin."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Type 2 Diabetes"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 1",
          "Phase 2"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "Randomized",
        "DesignInterventionModel": "Parallel Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "Single",
          "DesignWhoMaskedList": {
            "DesignWhoMasked": [
              "Participant"
            ]
          }
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "61",
        "EnrollmentType": "Actual"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "Cohort 1",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "MPC dose 1 or Placebo",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Drug: Mesenchymal Precursor Cells (MPCs)"
              ]
            }
          },
          {
            "ArmGroupLabel": "Cohort 2",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "MPC dose 2 or Placebo",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Drug: Mesenchymal Precursor Cells (MPCs)"
              ]
            }
          },
          {
            "ArmGroupLabel": "Cohort 3",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "MPC dose 3 or Placebo",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Drug: Mesenchymal Precursor Cells (MPCs)"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Drug",
            "InterventionName": "Mesenchymal Precursor Cells (MPCs)",
            "InterventionDescription": "Single intravenous infusion of MPCs Dose 1",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Cohort 1"
              ]
            }
          },
          {
            "InterventionType": "Drug",
            "InterventionName": "Mesenchymal Precursor Cells (MPCs)",
            "InterventionDescription": "Single intravenous infusion of MPCs Dose 2",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Cohort 2"
              ]
            }
          },
          {
            "InterventionType": "Drug",
            "InterventionName": "Mesenchymal Precursor Cells (MPCs)",
            "InterventionDescription": "Single intravenous infusion of MPCs Dose 3",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Cohort 3"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Primary objective of the study is to assess the safety and tolerability of MPC therapy",
            "PrimaryOutcomeDescription": "Outcomes include the measurement of the following safety parameters:\n\nAdverse events and serious adverse events(including hypoglycemia)\nVital signs (BP, HR, RR, O2 saturation)\nPhysical examinations\nResults of clinical laboratory tests (hematology, biochemistry, and urinalysis, flow cytometry Class I and Class II PRA % with specificity, antibovine and antimurine antibody analysis)\nPulmonary function test\nElectrocardiograms\nChest X-ray\nFundus oculi examination",
            "PrimaryOutcomeTimeFrame": "116 Weeks"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Key Inclusion Criteria:\n\nMale and female subjects who are ≥ 18 and ≤ 80 years old\nSubjects diagnosed with type 2 diabetes at least one year prior to Screening and receiving a stable, therapeutic dose of metformin > 1500 mg/day according to local prescribing information for at least 3 months prior to Screening or the highest tolerated dose > 1000 mg/day documented in the subject's history\nHbA1c > 7.0% and < 10.5% at Screening\nC-peptide > 0.8 ng/mL at Screening\nBody mass index (BMI) > 22 and < 45 kg/m2 at Screening\nBody weight < 150 kg at Screening\n\nKey Exclusion Criteria:\n\nPrior participation in any stem cell study\nWomen who are pregnant, intending to become pregnant during the study period or currently lactating\nHistory of active substance abuse (including alcohol) within the past 2 years. Current alcohol abuse is defined as daily consumption of >3 alcoholic beverage. Current cigarette smoking > 10 cigarettes per day\nSevere hypoglycemia (defined as requiring third party assistance) or repeated and/or frequent hypoglycemia episodes (> 2 episodes/week) within one month prior to Screening\nPatients receiving treatment for type 2 diabetes with diet and exercise alone, insulin therapy within 6 months of Screening except if used transiently for < 7 days for intercurrent illness or any other anti-diabetic medication except metformin within 3 months of Screening\nAny concurrent medical condition/disorder or clinically symptomatic cardiovascular, gastrointestinal (including pancreatitis), renal, hematological, pulmonary, acute or chronic infectious disease, active retinal disease, or other disorder which in the Investigator's opinion would interfere with the subject's ability to complete the trial, would require administration of treatment that could affect the interpretation of the safety and efficacy variables or would preclude safe involvement in the study.",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "18 Years",
      "MaximumAge": "80 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "K Segal, PhD",
            "OverallOfficialAffiliation": "Mesoblast, Ltd.",
            "OverallOfficialRole": "Study Director"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "SC Clinical Research",
            "LocationCity": "Garden Grove",
            "LocationState": "California",
            "LocationZip": "92844",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Diabetes Research Institute",
            "LocationCity": "Miami",
            "LocationState": "Florida",
            "LocationZip": "33136",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Compass Research",
            "LocationCity": "Orlando",
            "LocationState": "Florida",
            "LocationZip": "32806",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Pennington Biomedical Research Center",
            "LocationCity": "Baton Rouge",
            "LocationState": "Louisiana",
            "LocationZip": "70808",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Tulane University Medical Center",
            "LocationCity": "New Orleans",
            "LocationState": "Louisiana",
            "LocationZip": "70112",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Big Sky Clinical Research",
            "LocationCity": "Butte",
            "LocationState": "Montana",
            "LocationZip": "59701",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Desert Endocrinology Clinical Research Center-Henderson",
            "LocationCity": "Henderson",
            "LocationState": "Nevada",
            "LocationZip": "89052",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Alliance Against Diabetes/AAD Clinical Research",
            "LocationCity": "Las Vegas",
            "LocationState": "Nevada",
            "LocationZip": "89101",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Active Practices and Research",
            "LocationCity": "Newington",
            "LocationState": "New Hampshire",
            "LocationZip": "03801",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "The Carl and Edyth Lindner Center for Research and Education at The Christ Hospital",
            "LocationCity": "Cincinnati",
            "LocationState": "Ohio",
            "LocationZip": "45219",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Providence Health Partners - Center for Clinical Reseach",
            "LocationCity": "Dayton",
            "LocationState": "Ohio",
            "LocationZip": "45439",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Dallas Diabetes and Endocrine Center",
            "LocationCity": "Dallas",
            "LocationState": "Texas",
            "LocationZip": "75230",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "West Houston Clinical Research Services",
            "LocationCity": "Houston",
            "LocationState": "Texas",
            "LocationZip": "77055",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Paragon Research Center",
            "LocationCity": "San Antonio",
            "LocationState": "Texas",
            "LocationZip": "78205",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Wasatch Clinical Research",
            "LocationCity": "Salt Lake City",
            "LocationState": "Utah",
            "LocationZip": "84107",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "National Clinical Research - Norfolk, Inc",
            "LocationCity": "Norfolk",
            "LocationState": "Virginia",
            "LocationZip": "23502",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "National Clinical Research - Richmond, Inc.",
            "LocationCity": "Richmond",
            "LocationState": "Virginia",
            "LocationZip": "23294",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Capital Clinical Research Center",
            "LocationCity": "Olympia",
            "LocationState": "Washington",
            "LocationZip": "98502",
            "LocationCountry": "United States"
          }
        ]
      }
    },
    "ReferencesModule": {
      "ReferenceList": {
        "Reference": [
          {
            "ReferencePMID": "26153271",
            "ReferenceType": "derived",
            "ReferenceCitation": "Skyler JS, Fonseca VA, Segal KR, Rosenstock J; MSB-DM003 Investigators. Allogeneic Mesenchymal Precursor Cells in Type 2 Diabetes: A Randomized, Placebo-Controlled, Dose-Escalation Safety and Tolerability Pilot Study. Diabetes Care. 2015 Sep;38(9):1742-9. doi: 10.2337/dc14-2830. Epub 2015 Jul 7."
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000003920",
            "ConditionMeshTerm": "Diabetes Mellitus"
          },
          {
            "ConditionMeshId": "D000003924",
            "ConditionMeshTerm": "Diabetes Mellitus, Type 2"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000044882",
            "ConditionAncestorTerm": "Glucose Metabolism Disorders"
          },
          {
            "ConditionAncestorId": "D000008659",
            "ConditionAncestorTerm": "Metabolic Diseases"
          },
          {
            "ConditionAncestorId": "D000004700",
            "ConditionAncestorTerm": "Endocrine System Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M6267",
            "ConditionBrowseLeafName": "Diabetes Mellitus",
            "ConditionBrowseLeafAsFound": "Diabetes",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M6271",
            "ConditionBrowseLeafName": "Diabetes Mellitus, Type 2",
            "ConditionBrowseLeafAsFound": "Type 2 Diabetes",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M10791",
            "ConditionBrowseLeafName": "Metabolic Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M24556",
            "ConditionBrowseLeafName": "Glucose Metabolism Disorders",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M7014",
            "ConditionBrowseLeafName": "Endocrine System Diseases",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC18",
            "ConditionBrowseBranchName": "Nutritional and Metabolic Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC19",
            "ConditionBrowseBranchName": "Gland and Hormone Related Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          }
        ]
      }
    },
    "InterventionBrowseModule": {
      "InterventionBrowseLeafList": {
        "InterventionBrowseLeaf": [
          {
            "InterventionBrowseLeafId": "M10819",
            "InterventionBrowseLeafName": "Metformin",
            "InterventionBrowseLeafRelevance": "low"
          }
        ]
      },
      "InterventionBrowseBranchList": {
        "InterventionBrowseBranch": [
          {
            "InterventionBrowseBranchAbbrev": "Hypo",
            "InterventionBrowseBranchName": "Hypoglycemic Agents"
          },
          {
            "InterventionBrowseBranchAbbrev": "All",
            "InterventionBrowseBranchName": "All Drugs and Chemicals"
          }
        ]
      }
    }
  }
}